S

Surgical Science Sweden AB
STO:SUS

Watchlist Manager
Surgical Science Sweden AB
STO:SUS
Watchlist
Price: 146.7 SEK 1.87% Market Closed
Market Cap: 7.5B SEK

EV/EBITDA
Enterprise Value to EBITDA

48.3
Current
41.2
Median
11.5
Industry
Higher than median
Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
48.3
=
Enterprise Value
6.9B SEK
/
EBITDA
142.3m SEK

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
24
2-Years Forward
EV/EBITDA
16
3-Years Forward
EV/EBITDA
11.5